AGP Wire

AGP

Beyon was ranked third on Great Place to Work Middle East’s 2026 Best Workplaces in Technology list, adding to six straight years of Great Place to Work Certification.

AGP

Stoney Creek Publishing has released Arthur Garson Jr.’s Why it matters: - Stoney Creek Publishing is positioning Arthur Garson Jr.’s new book as a tool for history education, critical thinking and media literacy. - The book aims to make major…

AGP

The Arab America Foundation has launched a nationwide mentorship program to connect Arab American professionals and community leaders with students, young professionals, entrepreneurs, and emerging leaders.

AGP

Steven C. Markoff has published a new book that examines the Israeli-Palestinian conflict through historical events, demographic data, land ownership records and voices from both sides.

AGP

The global 3D audio market is projected to rise from $7.81 billion in 2026 to $27.05 billion by 2035, driven by spatial audio adoption in streaming, gaming and XR. The forecast highlights how immersive audio is moving from a premium feature to a…

AGP

The Business Research Company says the global organoid kit market is set to rise from $1.31 billion in 2025 to $1.52 billion in 2026, with growth tied to drug discovery, personalized medicine and biomedical research.

AGP

The Grammy-winning quartet has released its fourth album, The Time Has Come, and submitted it for 2026 Grammy consideration.

AGP

The Business Research Company says the ocular drug delivery market is on track to grow from $19.16 billion in 2025 to $29.44 billion by 2030, driven by aging populations, chronic eye disease and new delivery technologies.

AGP

The Business Research Company says the oral thin films market grew from $4.99 billion in 2025 to $5.72 billion in 2026 and is projected to reach $9.82 billion by 2030. The report points to faster drug delivery, patient-friendly dosage forms and…

AGP

The Business Research Company says the ophthalmic medical lasers market will grow from $1.33 billion in 2025 to $1.89 billion by 2030, driven by aging populations, more laser-based eye procedures and AI-assisted guidance.

AGP

The medical needle-free injection market is projected to climb from $16.13 billion in 2025 to $29.21 billion by 2030, according to a new report from The Business Research Company.

AGP

The ophthalmic sutures market is projected to grow from $0.65 billion in 2026 to $0.87 billion by 2030, according to The Business Research Company.

AGP

The ophthalmic viscoelastic devices market is projected to grow from $2.72 billion in 2025 to $3.47 billion by 2030, driven by rising eye surgeries, aging populations and demand for safer procedures.

AGP

The Business Research Company says the global ophthalmic artificial intelligence-assisted diagnosis market will grow from $2.57 billion in 2026 to $5.03 billion by 2030, driven by rising eye disease rates, cloud-based tools and tele-ophthalmology….

AGP

The ophthalmic packaging market is projected to grow from $12.87 billion in 2026 to $20.77 billion by 2030, driven by rising eye disorder cases, preservative-free medications and demand for safer, more compliant packaging.

AGP

The optometry equipment market is projected to grow from $3.79 billion in 2025 to $5.5 billion by 2030 as aging populations, vision disorders and AI-assisted diagnostics lift demand.

AGP

The Business Research Company says the nuclear medicine diagnostics market will grow from $7.88 billion in 2025 to $8.84 billion in 2026, then climb to $13.77 billion by 2030. The report points to rising cancer rates, more PET imaging, and…

AGP

The oncology biomarkers market is projected to grow from $19.73 billion in 2026 to $33.63 billion by 2030, driven by personalized cancer treatment, liquid biopsy adoption and AI-led discovery.

AGP

The orthobiologics devices and equipment market is projected to grow from $5.99 billion in 2025 to $8.64 billion by 2030, driven by aging populations, musculoskeletal disorders and demand for minimally invasive orthopedic treatments.

AGP

The medical linear accelerator market is projected to grow from $4.35 billion in 2026 to $6 billion by 2030, driven by rising cancer cases, more precise radiotherapy tools and broader hospital investment.